共 34 条
[1]
Hinchcliff M., Varga J., Systemic sclerosis/Scleroderma: A treatable multisystem disease, Am Fam Physician, 78, pp. 961-968, (2010)
[2]
Proudman S.M., Stevens W.M., Sahhar J., Celermajer D., Pulmonary arterial hypertension in systemic sclerosis: The need for early detection and treatment, Intern Med J, 37, (2007)
[3]
Mouthon L., Berezne A., Brauner M., Kambouchner M., Guillevin L., Valeyre D., Interstitial lung disease in systemic sclerosis, Rev Mal Respir, 24, pp. 1-11, (2007)
[4]
Hunzelmann N., Brinckmann J., What are the new milestones in the pathogenesis of systemic sclerosis, Ann Rheum Dis, 69, SUPPL.1, (2010)
[5]
Avouac J., Walker U., Tyndall A., Kahan A., Matucci-Cerinic M., Allanore Y., Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: Results from the EULAR scleroderma trial and research group (EUSTAR) database, J Rheumatol, 37, pp. 1488-1501, (2010)
[6]
Sandusky S.B., McGuire L., Smith M.T., Wigley F.M., Haythornthwaite J.A., Fatigue: An overlooked determinant of physical function in scleroderma, Rheumatology (Oxford), 48, pp. 165-169, (2009)
[7]
Khanna D., Clements P.J., Furst D.E., Chon Y., Elashoff R., Roth M.D., Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: Results from the scleroderma lung study, Arthritis Rheum, 52, pp. 592-600, (2005)
[8]
Steen V.D., Clinical manifestations of systemic sclerosis, Semin Cutan Med Surg, 17, pp. 48-54, (1998)
[9]
Hudson M., Thombs B.D., Steele R., Panopalis P., Newton E., Baron M., Health-related quality of life in systemic sclerosis: A systematic review, Arthritis Rheum, 61, pp. 1112-1160, (2009)
[10]
Oliveira N.C., Dos Santos Sabbaq L.M., De Sa Pinto A.L., Borges C.L., Lima F.R., Aerobic exercise is safe and effective in systemic sclerosis, Int J Sports Med, 30, pp. 728-732, (2009)